Innovex International, Inc. (INVX)

From the record

Innovex International, Inc.'s filings since 2017 show 3 warning events of 2 kinds: a warning not to rely on past financial statements (8-K item 4.02, 2 times, the latest 2024-08-01); an auditor change (8-K item 4.01, the latest 2024-10-01) (its current reports).

From the record

Innovex International, Inc.'s 8 filed years say what it did: revenue went from $337 million in fiscal 2018 to $978 million in fiscal 2025, up 16.4% a year; it rose in 5 of 7 years; the deepest fall was 23% from fiscal 2019 to fiscal 2021; net income was positive in 5 of 8 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Innovex International, Inc.'s diluted share count grew about 30.2% a year, and dividends and buybacks returned about 21% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 30 sales (16 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Innovex International, Inc. earned about 8 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 24 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 17 cents per dollar of assets, and net share issuance: its share count grew 37.0% over the year (the filed statements).

From the record

Innovex International, Inc.'s standing among 16 graded names in its industry family: revenue of $978 million in fiscal 2025 ranks in the top 41% by size; a net margin of 8.5% ranks in the top 47%; revenue growth of 27.9% a year over the last 3 filed years ranks in the top 16% (its annual reports).

From the record

Innovex International, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $203 million against debt of $19 million leaves 14.5% of its assets as net cash, top 22% of its family; cash from operations less capital spending is 19.5% of revenue (top 16%); a gross margin of 31% (top 32%); research spending of 0.7% of revenue (bottom 19%) (its annual report).

From the record

Innovex International, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 27.9% a year over the last three filed years against 16.4% over all 8, speeding up (top 10% of its family); the newest year grew 48.1% (top 10%); research spending grew 38.9% a year (top 6%); capital spending grew 39.8% a year (top 18%) (its annual reports). Innovex International, Inc. reported 3 product lines in fiscal 2025: Product at $685 million (70%), Leasing at $167 million (17%), Service at $126 million (13%); 3 of 3 grew against the year before (its annual report).

From the record

Innovex International, Inc.'s newest year against its own record: revenue of $978 million in fiscal 2025 came in 24.5% above the $786 million its prior three years' pace pointed to (top 11% of its family); net income of $83 million against a prior three-year average of $93 million (bottom 39%); a net margin of 8.5% against 16% before (bottom 32%) (its annual reports).